Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement (Q37467382)

20 August 2017

1 reference

title

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement (English)

1 reference

20 August 2017

0 references

1 reference

5

1 reference

20 August 2017

8

1 reference

20 August 2017

Janusz Jankowski

7

0 references

Jack Cuzick

1

object named as

Jack Cuzick

1 reference

20 August 2017

Frank L. Meyskens, Jr.

9

object named as

Frank Meyskens

1 reference

20 August 2017

Florian Otto

2

1 reference

20 August 2017

John A Baron

3

1 reference

20 August 2017

Powel H Brown

4

1 reference

20 August 2017

Peter Greenwald

6

1 reference

20 August 2017

Hans Jörg Senn

10

1 reference

20 August 2017

Michael Thun

11

1 reference

20 August 2017

1 May 2009

1 reference

Lancet Oncology Commission

20 August 2017

1 reference

20 August 2017

10

1 reference

20 August 2017

5

1 reference

20 August 2017

501-507

1 reference

Aspirin and cancer risk: an updated quantitative review to 2005

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Prevalence and incidence of colorectal adenomas and cancer in asymptomatic persons.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin for the primary prevention of stroke and other major vascular events: meta-analysis and hypotheses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin and cancer risk: a summary review to 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Low-dose aspirin and incidence of colorectal tumors in a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

A prospective study of aspirin use and the risk for colorectal adenoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Risk factors for self-reported colon polyps.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin use, cancer, and polyps of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

COX-2: a molecular target for colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Physical exercise, use of Plantago ovata and aspirin, and reduced risk of colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin and colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin and colorectal cancer: the Leisure World cohort revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Aspirin dose and duration of use and risk of colorectal cancer in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

Cyclooxygenase-2 inhibitors in colorectal cancer prevention: counterpoint.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970035-X

7 January 2021

10.1016/S1470-2045(09)70035-X

Identifiers

DOI

1 reference

20 August 2017

1 reference